J 2021

Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2

KRTIČKA, Milan, Ladislav PLÁNKA, Lucy VOJTOVÁ, Vladimír NEKUDA, Premysl STASTNY et. al.

Základní údaje

Originální název

Lumbar Interbody Fusion Conducted on a Porcine Model with a Bioresorbable Ceramic/Biopolymer Hybrid Implant Enriched with Hyperstable Fibroblast Growth Factor 2

Autoři

KRTIČKA, Milan (203 Česká republika, domácí), Ladislav PLÁNKA (203 Česká republika, domácí), Lucy VOJTOVÁ (203 Česká republika, garant), Vladimír NEKUDA (203 Česká republika, domácí), Premysl STASTNY (203 Česká republika), Radek SEDLACEK (203 Česká republika), Adam BRINEK (203 Česká republika), Michaela KAVKOVA (203 Česká republika), Eduard GOPFERT (203 Česká republika), Vera HEDVICAKOVA (203 Česká republika), Michala RAMPICHOVA (203 Česká republika), Leoš KŘEN (203 Česká republika, domácí), Květoslava LIŠKOVÁ (203 Česká republika, domácí), Daniel IRA (703 Slovensko, domácí), Jana DORAZILOVA (203 Česká republika), Tomas SUCHY (203 Česká republika), Tomas ZIKMUND (203 Česká republika), Jozef KAISER, David STARÝ (203 Česká republika, domácí), Martin FALDYNA (203 Česká republika) a Martin TRUNEC (203 Česká republika)

Vydání

BIOMEDICINES, BASEL, MDPI, 2021, 2227-9059

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

10608 Biochemistry and molecular biology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.757

Kód RIV

RIV/00216224:14110/21:00122158

Organizační jednotka

Lékařská fakulta

UT WoS

000676188200001

Klíčová slova anglicky

micro-CT; biomechanics; histology; animal model; lumbar spinal fusion; tissue engineering; autograft; ceramic; collagen; FGF2

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 24. 8. 2021 14:20, Mgr. Tereza Miškechová

Anotace

V originále

Many growth factors have been studied as additives accelerating lumbar fusion rates in different animal models. However, their low hydrolytic and thermal stability both in vitro and in vivo limits their workability and use. In the proposed work, a stabilized vasculogenic and prohealing fibroblast growth factor-2 (FGF2-STAB(R)) exhibiting a functional half-life in vitro at 37 degrees C more than 20 days was applied for lumbar fusion in combination with a bioresorbable scaffold on porcine models. An experimental animal study was designed to investigate the intervertebral fusion efficiency and safety of a bioresorbable ceramic/biopolymer hybrid implant enriched with FGF2-STAB(R) in comparison with a tricortical bone autograft used as a gold standard. Twenty-four experimental pigs underwent L2/3 discectomy with implantation of either the tricortical iliac crest bone autograft or the bioresorbable hybrid implant (BHI) followed by lateral intervertebral fixation. The quality of spinal fusion was assessed by micro-computed tomography (micro-CT), biomechanical testing, and histological examination at both 8 and 16 weeks after the surgery. While 8 weeks after implantation, micro-CT analysis demonstrated similar fusion quality in both groups, in contrast, spines with BHI involving inorganic hydroxyapatite and tricalcium phosphate along with organic collagen, oxidized cellulose, and FGF2- STAB(R) showed a significant increase in a fusion quality in comparison to the autograft group 16 weeks post-surgery (p = 0.023). Biomechanical testing revealed significantly higher stiffness of spines treated with the bioresorbable hybrid implant group compared to the autograft group (p < 0.05). Whilst histomorphological evaluation showed significant progression of new bone formation in the BHI group besides non-union and fibrocartilage tissue formed in the autograft group. Significant osteoinductive effects of BHI based on bioceramics, collagen, oxidized cellulose, and FGF2-STAB(R) could improve outcomes in spinal fusion surgery and bone tissue regeneration.